Conversely, in the NASH group, IL-12 was positively correlated with NAFLD fibrosis score, while IL-10 did not demonstrate any correlations in this group, indicating that these patients lose IL-10 anti-inflammatory modulation and IL-12 may be related to the disease progression. Here, IL10 is linked to metabolic dysfunction-associated steatotic liver disease.